Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • Bitcoin CAD

    87,674.47
    +3,570.20 (+4.24%)
     
  • CMC Crypto 200

    1,372.43
    +59.81 (+4.56%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Company News For Jun 26, 2019

  • AbbVie Inc.’s ABBV shares plummeted 16.3% after the company announced that it had entered into an agreement to buy Allergan plc AGN in a $63 billion deal

  • Lennar Corporation’s LEN shares lost 6.2% after the company reported second quarter fiscal 2019 earnings per share of $1.30, lower than the year-ago quarter of $1.58 a share

  • Shares of Xencor, Inc. XNCR gained 13.9% after the company announced that it would replace HFF, Inc. HF in the S&P SmallCap 600

  • Shares of USANA Health Sciences, Inc. USNA gained 7.6% after the company announced that it would replace Fidelity Southern LION in the S&P SmallCap 600 on Jul 1, 2019


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
Allergan plc (AGN) : Free Stock Analysis Report
 
Fidelity Southern Corporation (LION) : Free Stock Analysis Report
 
Lennar Corporation (LEN) : Free Stock Analysis Report
 
Xencor, Inc. (XNCR) : Free Stock Analysis Report
 
USANA Health Sciences, Inc. (USNA) : Free Stock Analysis Report
 
HFF, Inc. (HF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research